This trial will use FDOPA/PET to see if it can help doctors better understand and treat congenital hyperinsulinism, a disorder where the pancreas produces too much insulin.
2 Primary · 1 Secondary · Reporting Duration: four weeks
50 Total Participants · 1 Treatment Group
Primary Treatment: 18F-Fluoro Dopa Imaging · No Placebo Group · Phase 2
Age No minimum age - 18 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: